Evidence map›Paper›PMID 41170432›Full record

ReviewFrontiers in microbiology2025

Research advances of the establishment and characterization of

Kaifang Zhang, Man Cui, Yuefeng Zhu, Songping Li, Guimin Su, Lin Du

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Integrated virulence-resistance profiling ofFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kaifang Zhang *School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
Man Cui *Beijing Zhifei lvzhu Biopharmaceutical Co., Ltd., Beijing, China.
Yuefeng ZhuBeijing Zhifei lvzhu Biopharmaceutical Co., Ltd., Beijing, China.
Songping LiSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
Guimin SuBeijing Zhifei lvzhu Biopharmaceutical Co., Ltd., Beijing, China.
Lin DuBeijing Zhifei lvzhu Biopharmaceutical Co., Ltd., Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

animal modelanimal species selectiondetectionestablishment methodsHelicobacter pyloriinfection modelquantification

Identifiers

PMID41170432
PMCPMC12568712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.